SCHEMBL15310575

SCHEMBL15310575

COc1cc(CC(CCCCCC(C)C)C(=O)O)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.61
CYP2D6 P10635 3/20 0.61
CYP2C9 P11712 3/20 0.61
CYP2C19 P33261 3/20 0.61
TSHR P16473 2/20 0.61
CYP1A2 P05177 2/20 0.61
MEN1 O00255 1/20 0.61
POLB P06746 1/20 0.61
BLM P54132 1/20 0.61
PMP22 Q01453 1/20 0.61
KMT2A Q03164 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
FOS P01100 1/20 0.56
TTR P02766 1/20 0.56
JUN P05412 1/20 0.56
NR3C1 P04150 1/20 0.56
HSD17B1 P14061 1/20 0.56
HSD17B2 P37059 1/20 0.56
ALOX15 P16050 1/20 0.52
ALOX12 P18054 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27870957 0.99 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9CYP2C19TSHR
SCHEMBL18043458 0.94 FOS (0.59) CYP3A4CYP2D6CYP2C9CYP2C19TSHR
SCHEMBL18043454 0.91 FOS (0.59) CYP3A4CYP2D6CYP2C9CYP2C19TSHR
SCHEMBL5047574 0.90 HTR1A (0.60) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL5051127 0.90 HTR1A (0.60) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL22462684 0.90 HTR1A (0.60) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL5047559 0.90 HTR1A (0.60) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL28447253 0.86 HTR1A (0.56) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL29291131 0.84 FOS (0.57) CYP3A4CYP2C9CYP2C19TSHRCYP1A2
SCHEMBL19127736 0.84 MMP1 (0.58) CYP3A4TSHRPOLBBLMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627634-B1 Use of capsinoids for the treatment of arteriosclerosis AJINOMOTO KK (JP) 2013-10-16 EP claimed